Brevan Howard Capital Management’s Celldex Therapeutics CLDX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-11,414	Closed	-$288K	–	1150
2024 Q4	$288K	Sell	11,414 -6,401	-36%	-$162K	﹤0.01%	759
2024 Q3	$606K	Buy	17,815 +6,870	+63%	+$234K	﹤0.01%	575
2024 Q2	$405K	Buy	+10,945	New	+$405K	﹤0.01%	628